GlassScriptPhysician profile
Michael W Jones
NPI 1477525269
$367.35
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $99.76 · 2021: $144.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $144.34 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.88 | 2019-2020 | |
| Pfizer INC. | $22.55 | 2019 | |
| Alkermes, INC. | $20.82 | 2020 | |
| Astellas Pharma US INC | $20.43 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $19.10 | 2019 | |
| Allergan, INC. | $13.15 | 2019 | |
| Shire North American Group INC | $12.92 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.46 | 2019 | |
| Glaxosmithkline, LLC. | $11.70 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.